FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Sharon Walmsley

Research Profile

Disorders

Living Beings

HIV-1

Concepts & Ideas

Chemicals & Drugs

Procedures

Geographic Areas

Canada

Co-author Network

Publications

TOP 3
Olena Kis; Sharon L Walmsley; Jason Zastre; Md Tozammel Hoque; Reina Bendayan
Role of drug efflux and uptake transporters in atazanavir intestinal permeability and drug-drug interactions.
Leah Szadkowski; Alice Tseng; Sharon L Walmsley; Irving Salit; Janet M Raboud
Short communication: effects of age on virologic suppression and CD4 cell response in HIV-positive patients initiating combination antiretroviral therapy.
Jeff E Powis; Janet Raboud; Colin Kovacs; Mona R Loutfy; Mario Ostrowski; Sharon L Walmsley
The recombinant hepatitis B surface antigen vaccine in persons with HIV: is seroconversion sufficient for long-term protection?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Sharon Walmsley (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Olena Kis; Sharon L Walmsley; Jason Zastre; Md Tozammel Hoque; Reina Bendayan
Role of drug efflux and uptake transporters in atazanavir intestinal permeability and drug-drug interactions.
Pharmaceutical research 2013;30(4):1050-64.
2012: Leah Szadkowski; Alice Tseng; Sharon L Walmsley; Irving Salit; Janet M Raboud
Short communication: effects of age on virologic suppression and CD4 cell response in HIV-positive patients initiating combination antiretroviral therapy.
AIDS research and human retroviruses 2012;28(12):1579-83.
2012: Jeff E Powis; Janet Raboud; Colin Kovacs; Mona R Loutfy; Mario Ostrowski; Sharon L Walmsley
The recombinant hepatitis B surface antigen vaccine in persons with HIV: is seroconversion sufficient for long-term protection?
The Journal of infectious diseases 2012;205(10):1534-8.
2010: Mona R Loutfy; Miguel Genebat; David Moore; Janet Raboud; Keith Chan; Tony Antoniou; David Milan; Anya Shen; Marina B Klein; Curtis Cooper; Nima Machouf; Sean B Rourke; Anita Rachlis; Chris Tsoukas; Julio S G Montaner; Sharon L Walmsley; Marek Smieja; Ahmed M Bayoumi; Edward Mills; Hogg Robert
A CD4+ cell count <200 cells per cubic millimeter at 2 years after initiation of combination antiretroviral therapy is associated with increased mortality in HIV-infected individuals with viral suppression.
Journal of acquired immune deficiency syndromes (1999) 2010;55(4):451-9.
2008: Sharon L Walmsley; Christine Katlama; Adriano Lazzarin; Keikawus Arestéh; Gerald Pierone; Gary Blick; Margaret Johnson; Ulrich Meier; Thomas R MacGregor; Johnathan G Leith
Pharmacokinetics, safety, and efficacy of tipranavir boosted with ritonavir alone or in combination with other boosted protease inhibitors as part of optimized combination antiretroviral therapy in highly treatment-experienced patients (BI Study 1182.51).
Journal of acquired immune deficiency syndromes (1999) 2008;47(4):429-40.
2007: Sharon L Walmsley; Laurent Cotte; Stefano Rusconi; Douglas J Ward; Charles B Hicks; Ulrich Meier; Hernan Valdez; Charles A B Boucher
Treatment response to ritonavir-boosted tipranavir versus ritonavir-boosted lopinavir in HIV-1 patients with higher lopinavir mutation scores.
AIDS (London, England) 2007;21(16):2245-8.
2007: Mona R Loutfy; M Harris; Janet Raboud; Tony Antoniou; Colin Kovacs; S Shen; S Dufresne; Fiona Smaill; Danielle Rouleau; Anita Rachlis; Kevin Gough; R Lalonde; C Tsoukas; Benoit Trottier; Sharon L Walmsley; Julio S G Montaner
A large prospective study assessing injection site reactions, quality of life and preference in patients using the Biojector vs standard needles for enfuvirtide administration.
HIV medicine 2007;8(7):427-32.
2007: Mona R Loutfy; Nabil Ackad; Tony Antoniou; Jean-Guy Baril; Brian Conway; Joss de Wet; Benoit Trottier; Colin Kovacs; William Thompson; Alain Y Martel; Sylvie Trottier; Danielle Rouleau; Stephen D Shafran; Anita Rachlis; Christopher Fraser; Fiona Smaill; Sharon L Walmsley; Alice L Tseng; John S Sampalis
Randomized controlled trial of once-daily tenofovir, lamivudine, and lopinavir/ritonavir versus remaining on the same regimen in virologically suppressed HIV-infected patients on their first PI-containing HAART regimen.
HIV clinical trials 2007;8(5):259-68.
2007: Jacques Reynes; Keikawus Arastéh; Bonaventura Clotet; Calvin Cohen; David A Cooper; Jean-François Delfraissy; Joseph J Eron; Keith Henry; Christine Katlama; Daniel R Kuritzkes; Jacob P Lalezari; Joep Lange; Adriano Lazzarin; Julio S G Montaner; Mark Nelson; Mary O' Hearn; Hans-Jürgen Stellbrink; Benoit Trottier; Sharon L Walmsley; Neil E Buss; Ralph DeMasi; Jain Chung; Lucille Donatacci; Denise Guimaraes; Lucy Rowell; Adeline Valentine; Martin Wilkinson; Miklos Salgo
TORO: ninety-six-week virologic and immunologic response and safety evaluation of enfuvirtide with an optimized background of antiretrovirals.
AIDS patient care and STDs 2007;21(8):533-43.
2007: Sharon L Walmsley; Anona Thorne; Mona R Loutfy; Natasha LaPierre; John MacLeod; Richard Harrigan; Benoit Trottier; Brian Conway; Joy R Hay; Joel Singer; Don Zarowny
A prospective randomized controlled trial of structured treatment interruption in HIV-infected patients failing highly active antiretroviral therapy (Canadian HIV Trials Network Study 164).
Journal of acquired immune deficiency syndromes (1999) 2007;45(4):418-25.
2007: Mona R Loutfy; Janet Raboud; Julio S G Montaner; Tony Antoniou; Brian Wynhoven; Fiona Smaill; Danielle Rouleau; J Gill; Walter F Schlech; Zabrina L Brumme; Theresa Mo; Kevin Gough; Anita Rachlis; P R Harrigan; Sharon L Walmsley
Assay of HIV gp41 amino acid sequence to identify baseline variation and mutation development in patients with virologic failure on enfuvirtide.
Antiviral research 2007;75(1):58-63.
2007: Catherine M Tansey; Marie Louie; Mark Loeb; Wayne L Gold; Matthew P Muller; JoAnne de Jager; Jill I Cameron; George Tomlinson; Tony Mazzulli; Sharon L Walmsley; Anita Rachlis; Barbara Mederski; Mike Silverman; Zev Shainhouse; Issa E Ephtimios; Monica Avendano; James Downey; Rima Styra; Deborah Yamamura; Marvin Gerson; Matthew B Stanbrook; Theodore K Marras; Elizabeth J Phillips; Noë Zamel; Susan E Richardson; Arthur Slutsky; Margaret S Herridge
One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome.
Archives of internal medicine 2007;167(12):1312-20.
2006: Joseph C Gathe; David A Cooper; Charles Farthing; Dushyantha Jayaweera; Dorece Norris; Gerald Pierone; Corklin R Steinhart; Benoit Trottier; Sharon L Walmsley; Cassy Workman; Geoffrey Mukwaya; Veronika Kohlbrenner; Catherine Dohnanyi; Scott McCallister; Douglas Mayers
Efficacy of the protease inhibitors tipranavir plus ritonavir in treatment-experienced patients: 24-week analysis from the RESIST-1 trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43(10):1337-46.
2006: Charles B Hicks; Pedro Cahn; David A Cooper; Sharon L Walmsley; Christine Katlama; Bonaventura Clotet; Adriano Lazzarin; Margaret A Johnson; Dietmar Neubacher; Douglas Mayers; Hernan Valdez
Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug reSistant patients with Tipranavir (RESIST) studies: an analysis of combined data from two randomised open-label trials.
Lancet 2006;368(9534):466-75.
2006: Sharon L Walmsley; Janet Raboud; Jonathan B Angel; Tony Mazzulli; Sandy Shen; Lidia Casciaro; Charlene Young; George Moussa; Kevin Gough; Anita Rachlis; Jill Hopkins
Long-term follow-up of a cohort of HIV-infected patients who discontinued maintenance therapy for cytomegalovirus retinitis.
HIV clinical trials 2006;7(1):1-9.
2005: Mark Nelson; Keikawus Arastéh; Bonaventura Clotet; David A Cooper; Keith Henry; Christine Katlama; Jacob P Lalezari; Adriano Lazzarin; Julio S G Montaner; Mary E O'Hearn; Peter J Piliero; Jacques Reynes; Benoit Trottier; Sharon L Walmsley; Calvin Cohen; Joseph J Eron; Daniel R Kuritzkes; Joep Lange; Hans-Jürgen Stellbrink; Jean-François Delfraissy; Neil E Buss; Lucille Donatacci; Cynthia Wat; Lynn Smiley; Martin Wilkinson; Adeline Valentine; Denise Guimaraes; Ralph DeMasi; Jain Chung; Miklos Salgo
Durable efficacy of enfuvirtide over 48 weeks in heavily treatment-experienced HIV-1-infected patients in the T-20 versus optimized background regimen only 1 and 2 clinical trials.
Journal of acquired immune deficiency syndromes (1999) 2005;40(4):404-12.
2005: Mona R Loutfy; Sharon L Walmsley; Christopher M Mullin; George Perez; James D Neaton
CD4(+) cell count increase predicts clinical benefits in patients with advanced HIV disease and persistent viremia after 1 year of combination antiretroviral therapy.
The Journal of infectious diseases 2005;192(8):1407-11.
2004: Mona R Loutfy; Janet Raboud; Sharon L Walmsley; Refik Saskin; Julio S G Montaner; Hogg Robert; Courtney A Thompson; P Richard Harrigan
Predictive value of HIV-1 protease genotype and virtual phenotype on the virological response to lopinavir/ritonavir-containing salvage regimens.
Antiviral therapy 2004;9(4):595-602.
2004: Mona R Loutfy; Sharon L Walmsley
Treatment of HIV infection in pregnant women: antiretroviral management options.
Drugs 2004;64(5):471-88.
2003: David R Burdge; Deborah M Money; John C Forbes; Sharon L Walmsley; Fiona Smaill; Marc Boucher; Lindy M Samson; Marc Steben
Canadian consensus guidelines for the care of HIV-positive pregnant women: putting recommendations into practice.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2003;168(13):1683-8.
2003: David R Burdge; Deborah M Money; John C Forbes; Sharon L Walmsley; Fiona Smaill; Marc Boucher; Lindy M Samson; Marc Steben
Canadian consensus guidelines for the management of pregnancy, labour and delivery and for postpartum care in HIV-positive pregnant women and their offspring (summary of 2002 guidelines).
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2003;168(13):1671-4.
2003: Christopher M Booth; Larissa M Matukas; George A Tomlinson; Anita Rachlis; David B Rose; Hy A Dwosh; Sharon L Walmsley; Tony Mazzulli; Monica Avendano; Peter Derkach; Issa E Ephtimios; Ian Kitai; Barbara Mederski; Steven B Shadowitz; Wayne L Gold; Laura Hawryluck; Elizabeth Rea; Jordan S Chenkin; David W Cescon; Susan M Poutanen; Allan S Detsky
Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.
JAMA : the journal of the American Medical Association 2003;289(21):2801-9.
2003: Mona R Loutfy; Nancy Sheehan; John E Goodhew; Sharon L Walmsley
Inclusion body myositis: another possible manifestation of antiretroviral-associated mitochondrial toxicity.
AIDS (London, England) 2003;17(8):1266-7.
2002: Stephen D Shafran; Laura D Mashinter; Peter Phillips; Richard G Lalonde; M John Gill; Sharon L Walmsley; Emil Toma; Brian Conway; Ignatius W Fong; Anita Rachlis; Kurt E Williams; Gary E Garber; Walter F Schlech; Fiona Smaill; C Pradier
Successful discontinuation of therapy for disseminated Mycobacterium avium complex infection after effective antiretroviral therapy.
Annals of internal medicine 2002;137(9):734-7.
2002: Kevin C Katz; Sharon L Walmsley; Anne G McLeod; Jay S Keystone; Allan S Detsky
Clinical problem-solving. Where are you from?
The New England journal of medicine 2002;346(10):764-7.
2002: Stephen D Shafran; Brian Conway; Errol Prasad; Jane Greer; Jean Vincelette; C Edward Ellis; David A Haase; Sharon L Walmsley; Richard G Lalonde; William Cameron
Field evaluation of the Merlin immediate HIV-1 and -2 test for point-of-care detection of human immunodeficiency virus antibodies.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(5):658-61.
2002: Mona R Loutfy; Sharon L Walmsley
Salvage antiretroviral therapy in HIV infection.
Expert opinion on pharmacotherapy 2002;3(2):81-90.
2001: Sharon L Walmsley; Deborah V Kelly; Alice L Tseng; A Humar; P R Harrigan
Non-nucleoside reverse transcriptase inhibitor failure impairs HIV-RNA responses to efavirenz-containing salvage antiretroviral therapy.
AIDS (London, England) 2001;15(12):1581-4.
2001: Christos M Tsoukas; H M Turner; George E Hatzakis; G P Blake; J E Goodhew; D L Kilby; Colin Kovacs; J R Luetkehoelter; Jean-Pierre Routy; Sharon L Walmsley; Nicole F Bernard
Improvement of HIV-specific immunity in HIV-infected twins treated with highly active antiretroviral therapy, interleukin 2, and syngeneic adoptively transferred cells.
AIDS research and human retroviruses 2001;17(10):887-900.
2001: Sharon L Walmsley; M I Becker; M Zhang; A Humar; P R Harrigan
Predictors of virological response in HIV-infected patients to salvage antiretroviral therapy that includes nelfinavir.
Antiviral therapy 2001;6(1):47-54.
2001: Matthew P Muller; D C Richardson; Sharon L Walmsley
Trimethoprim-sulfamethoxazole induced aseptic meningitis in a renal transplant patient.
Clinical nephrology 2001;55(1):80-4.
2000: Kevin C Katz; Sharon L Walmsley
Postoperative tetanus: a case report.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2000;163(5):571-3.
2000: Dorothee Bienzle; Kelly S MacDonald; Fiona Smaill; Colin Kovacs; M Baqi; B Courssaris; Mark A Luscher; Sharon L Walmsley; Kenneth L Rosenthal
Factors contributing to the lack of human immunodeficiency virus type 1 (HIV-1) transmission in HIV-1-discordant partners.
The Journal of infectious diseases 2000;182(1):123-32.
1998: Sharon L Walmsley; S Khorasheh; Joel Singer; O Djurdjev
A randomized trial of N-acetylcysteine for prevention of trimethoprim-sulfamethoxazole hypersensitivity reactions in Pneumocystis carinii pneumonia prophylaxis (CTN 057). Canadian HIV Trials Network 057 Study Group.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1998;19(5):498-505.
1998: Stephen D Shafran; James A Talbot; Sylvia Chomyc; E Davison; Joel Singer; Peter Phillips; Irving E Salit; Sharon L Walmsley; Ignatius W Fong; M John Gill; Anita Rachlis; Richard G Lalonde
Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin? Canadian HIV Trials Network Protocol 010 Study Group.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;27(6):1401-5.
1998: Johane P Allard; Elaheh Aghdassi; J Chau; Cynthia Tam; Colin Kovacs; Irving E Salit; Sharon L Walmsley
Effects of vitamin E and C supplementation on oxidative stress and viral load in HIV-infected subjects.
AIDS (London, England) 1998;12(13):1653-9.
1997: Sharon L Walmsley; Louise M Winn; M L Harrison; Jack P Uetrecht; Peter G Wells
Oxidative stress and thiol depletion in plasma and peripheral blood lymphocytes from HIV-infected patients: toxicological and pathological implications.
AIDS (London, England) 1997;11(14):1689-97.
1997: M Baqi; W Kucharczyk; Sharon L Walmsley
Regression of progressive multifocal encephalopathy with highly active antiretroviral therapy.
AIDS (London, England) 1997;11(12):1526-7.